Department of Microbiology and Immunology, University of Western Ontario, London, ON, Canada, N6A 5C1.
Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
Nat Commun. 2019 Feb 15;10(1):775. doi: 10.1038/s41467-019-08724-x.
Staphylococcus aureus is a significant cause of human infection. Here, we demonstrate that mutations in the transcriptional repressor of purine biosynthesis, purR, enhance the pathogenic potential of S. aureus. Indeed, systemic infection with purR mutants causes accelerated mortality in mice, which is due to aberrant up-regulation of fibronectin binding proteins (FnBPs). Remarkably, purR mutations can arise upon exposure of S. aureus to stress, such as an intact immune system. In humans, naturally occurring anti-FnBP antibodies exist that, while not protective against recurrent S. aureus infection, ostensibly protect against hypervirulent S. aureus infections. Vaccination studies support this notion, where anti-Fnb antibodies in mice protect against purR hypervirulence. These findings provide a novel link between purine metabolism and virulence in S. aureus.
金黄色葡萄球菌是人类感染的重要原因。在这里,我们证明嘌呤生物合成的转录抑制剂 purR 的突变增强了金黄色葡萄球菌的致病潜力。事实上,用 purR 突变体进行全身性感染会导致小鼠死亡加速,这是由于纤维连接蛋白结合蛋白 (FnBPs) 的异常上调。值得注意的是,金黄色葡萄球菌在受到压力(如完整的免疫系统)时会产生 purR 突变。在人类中,存在天然存在的抗 FnBP 抗体,尽管它们不能预防金黄色葡萄球菌的复发性感染,但显然可以预防高毒力金黄色葡萄球菌的感染。疫苗接种研究支持这一观点,即小鼠中的抗 Fnb 抗体可预防 purR 超强毒力。这些发现为金黄色葡萄球菌嘌呤代谢与毒力之间提供了新的联系。